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Abstract 
Background: Vibrio cholerae, a Gram-negative, non-spore forming curved rod is found in diverse aquatic ecosystems 
around the planet. It is classified according to its major surface antigen into around 206 serogroups, of which O1 and 
O139 cause epidemic cholera. A recent spatial modelling technique estimated that around 2.86 million cholera cases 
occur globally every year, and of them approximately 95,000 die. About 1.3 billion people are currently at risk of infec-
tion from cholera. Meta-analysis and mathematical modelling have demonstrated that due to global warming the 
burden of vector-borne diseases like malaria, leishmaniasis, meningococcal meningitis, viral encephalitis, dengue and 
chikungunya will increase in the coming years in the tropics and beyond.
Cholera and climate: This review offers an overview of the interplay between global warming and the pathogenic-
ity and epidemiology of V. cholerae. Several distinctive features of cholera survival (optimal thriving at 15% salinity, 
30 °C water temperature, and pH 8.5) indicate a possible role of climate change in triggering the epidemic process. 
Genetic exchange (ctxAB, zot, ace, cep, and orfU) between strains and transduction process allows potential emer-
gence of new toxigenic clones. These processes are probably controlled by precise environmental signals such as 
optimum temperature, sunlight and osmotic conditions. Environmental influences on phytoplankton growth and 
chitin remineralization will be discussed alongside the interplay of poor sanitary conditions, overcrowding, improper 
sewage disposal and global warming in promoting the growth and transmission of this deadly disease.
Conclusion: The development of an effective early warning system based on climate data could help to prevent 
and control future outbreaks. It may become possible to integrate real-time monitoring of oceanic regions, climate 
variability and epidemiological and demographic population dynamics to predict cholera outbreaks and support the 
design of cost-effective public health strategies.
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Background
Vibrio cholera (V. cholerae), which causes outbreaks 
resulting in massive disease burden, is a Gram-negative, 
non-spore-forming curved rod. V. cholerae is an autoch-
thonous member of diverse aquatic ecosystems around 
the planet, and is often found in close association with 
a variety of algae and crustaceans [1]. The World Health 
Organization estimates that officially reported cases of 
cholera represent only 5–10% of the actual case num-
ber occurring annually worldwide [2]. A recent spatial 
modelling technique estimated that around 2.86 mil-
lion cholera cases occur globally every year, and of them 
approximately 95,000 die [3]. About 1.3 billion people are 
currently at risk of being infected with cholera [3].
The bacterium is classified by the composition of its 
major surface antigen (O) from lipopolysaccharide into 
serogroups, of which there are nearly 206 [4]. Only two 
serogroups of V. cholerae, O1 and O139, have been con-
sidered causative agents of cholera [4]. The V. cholerae 
O1 strain is further divided into two biotypes named 
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El Tor and classical, on the basis of biochemical differ-
ences and bacteriophage susceptibility (Fig. 1). It is gen-
erally accepted that seven distinct cholera pandemics 
have occurred since the onset of the first report in 1817 
and the seventh one in 1961 in Egypt [5]. It reappeared 
dramatically and unexpectedly in January 1991 in Latin 
America as a continuation of seventh pandemic after 
a hiatus in that region of more than a century [6]. The 
appearance in late 1992 in southern India of an epidemic 
strain of V. cholerae, O139 Bengal has caused global 
concern [7, 8]. This concern was probably unwarranted 
as the prevalence of O139 cases seems to be receding. 
It has been hypothesised that the serological switch-
ing and genetic diversity of strains between pandemics 
and epidemics may be influenced by climate variations, 
with global warming making the environment favourable 
for cholera outbreaks by switching of virulence factors. 
This hypothesis is supported by studies of V. cholerae 
outbreaks in India [9], Bangladesh [10] and China [11], 
as well as a literature review of the influence of environ-
mental factors on V. cholerae presence [12]. Furthermore, 
experimental studies have demonstrated variation with 
changes in environmental conditions in expression of 
ChiA2 and TfoX, key regulators of V. cholerae horizon-
tal gene transfer [13]. Warmer conditions also provide 
enriched food sources and ecological protection for the 
organism by causing algae blooms and making availability 
of chitin. The delta region of the Ganges and the Brahma-
putra have been identified as cholera’s ‘native habitat’ for 
centuries, and the source for periodic pandemic spread 
[14]. Of the 36 countries that reported cholera in the sev-
enth pandemic, 28 were newly affected countries and 16 
were in Africa [15]. Outbreaks or cases have since been 
reported in Pakistan, Nepal, China, Thailand, Kazakh-
stan, Afghanistan, and Malaysia, Sierra Leone, The 
Democratic Republic of Congo, Nigeria, Angola and 
Zimbabwe [16–20]. Since the beginning of the century 
the cholera prevalence has massively expanded on the 
African continent. In 2015 the majority of cholera cases 
and mortality were reported from sub-Saharan Africa 
[21]. Imported cases have been reported in the United 
Kingdom and United States amongst other countries and 
in Haiti after the massive earthquake [17, 22–24].
The Haiti outbreak in 2010 was thought to be imported 
from South Asia by United Nations peace keeping forces 
[24–26]. Analysis of local climatic variables suggested 
that following importation, other factors contributed to 
propagation of the outbreak. The average air temperature 
and rainfall preceding the outbreak in Haiti was signifi-
cantly above the long term average of that region [27]. In 
addition, destruction of sanitary infrastructure and lack 
of safe water made the situation more vulnerable for the 
habitant [27]. The cholera outbreak in Haiti supports the 
suggested role of climatic factors in the transmission of 
cholera. This review will explore the interplay between 
environmental influences, changing virulence factors and 
the molecular epidemiology of cholera.
Variation of strain (serotype and biotype) 
during epidemic and pandemic
The V. cholerae strain type causing the first four pandem-
ics are unknown. The fifth and sixth pandemics were 
caused by the classical biotype of O1 strains whereas the 
seventh was due to the El Tor biotype. In 1992 an epi-
demic clone of a non-O1 strain with serogroup O139 
Bengal caused a large cholera outbreak in Bangladesh 
and neighbouring countries [8, 28]. At the beginning of 
the outbreak, the O139 strain displaced the V. cholerae 
O1 strains, including both classical and El Tor biotypes, 
which coexisted only in Bangladesh. The subsequent 
emergence of a new clone of V. cholerae O1 El Tor that 
transiently displaced the O139 strains during 1994 and 
1995, and the re-emergence in 1996 of V. cholerae O139 
as the main cause of cholera in Calcutta and its coex-
istence with the O1 El Tor strains demonstrated tem-
poral changes in the epidemiology of cholera [29, 30]. 
These clones are genetically (different ctx genotype and 
ribotype) different compared to other co-existing global 
clones (the Mexican Gulf coast clone, and the Australian 
clone) [31].
If we consider these events from a different angle, this 
heterogeneity of clones might not be due to serologi-
cal switching but emergence of a new toxigenic strain. 
Transient appearance and disappearance of more than 
six ribotypes of classical Vibrios [32–34], at least five 
ribotypes of El Tor Vibrios [31], and three different 
Fig. 1 Classification of Vibrio cholera. V. cholerae is classified firstly 
by serotype. O1 is subdivided into two biotypes, classic and El Tor 
on the basis of phenotypic characteristics (although genetic hybrids 
between the V. cholerae O1 classic and El Tor biotypes have been 
reported). Organisms in both biotypes are further classified according 
to the presence of somatic antigens into two major serotypes (Inaba 
and Ogawa) and an unstable intermediate type (Hikojima)
Page 3 of 6Chowdhury et al. Ann Clin Microbiol Antimicrob  (2017) 16:10 
ribotypes of V. cholerae O139 [35, 36] during epidemics 
between 1961 and 1996 in Bangladesh have been dem-
onstrated. Genetic diversity among clinical and environ-
mental isolates during and between epidemics over the 
past 20  years were also found [34, 37]. All these stud-
ies indicate that there has been a continual emergence 
of new clones of toxigenic V. cholerae replacing exist-
ing clones. The question is what factors contribute to 
this shifting? We hypothesize that the clonal shifting in 
V. cholerae is driven chiefly by environmental variations 
rather than by human-borne dissemination.
Virulence factor and transduction
Naturally occurring strains of toxigenic V. cholerae O1 
and O139 contain the virulent enterotoxin cholera toxin 
(CT). The genes encoding CT (ctxAB) are part of a larger 
genetic element (CTX genetic element) consisting of at 
least six genes (ctxAB, zot, ace, cep, and orfU) [38]. The 
entire CTX element constituted the genome of a filamen-
tous bacteriophage (CTXф) [38]. Genetic exchange in 
the environment allows the potential emergence of new 
toxigenic clones by lysogenic (self-replicating element) 
conversion with a filamentous bacteriophage (CTXф). 
CTXф encodes cholera toxin including its receptor, and 
the toxin-co regulated Pilus (TCP), another important 
virulence factor [38]. CTXф confers increased evolu-
tionary fitness to its host and hence to its own nucleic 
acids. With growing immunity in the host population 
against certain toxigenic clones of V. cholera, new toxi-
genic clones emerge and replace existing clones by a pro-
cess of natural selection. Novel clone emergence may also 
happen by transduction. Transduction is the process by 
which DNA is transferred from one bacterium to another 
by a bacteriophage. Genes for both TCP and CTX (vir-
ulence factor) can be readily transduced into recipient 
strains via temperate phages [29]. Induction of CTXф 
lysogens is probably controlled by precise environmen-
tal signals such as optimum temperature, sunlight, and 
osmotic conditions [29]. Exposure to sunlight is a key 
factor in the induction of CTX prophase from the host 
and subsequent propagation of the phage particle [27, 
29, 39]. The continual emergence of new strains of toxi-
genic V. cholera and their selective enrichment during 
cholera outbreaks constitute an essential component of 
the ecosystem for their survival. Goel et  al. investigated 
two subsequent epidemics in India by genomic finger 
printing analysis. They have identified heavy rainfall as 
the plausible cause of genotype switching between O1 
and O139 type strain. The duration between two peaks 
and switching was only 2  weeks [9]. Koelle et  al. also 
showed in Bangladesh through a phenotypical model-
ling that shifting in V. cholerae serotype is driven chiefly 
by environmental variations rather than by human-borne 
dissemination [10]. The reason behind is the pathogen’s 
sensitivity to environmental fluctuations. El Tor, a sea-
sonal generalist, seems to gain an advantage over the 
classical strain, a seasonal specialist, when monsoon 
rainfall becomes more extreme [10]. This is because El 
Tor is known to be more fit then classical type because of 
the expression of vibrio polysaccharide (vps) gene which 
provide a protection to them against climatic variables 
[10]. This molecular difference therefore establishes the 
trade-off between maximum transmission and sensitivity 
to climatic fluctuations between the serotypes [10].
Presence of virulence factors in environmental 
strain
Another alarming feature for cholera control is the pres-
ence of these virulence factors in environmental or non-
toxigenic strains (non O1 and non-O139) of V. cholerae. 
Ghosha et  al. identified the presence of virulence-asso-
ciated genes like ctxA, tcpA, toxR and the repetitive 
sequence (RS element) in both non O1 and non-O139 
strains [40]. They suggested that a new toxigenic strain 
could evolve from these strains in favourable conditions. 
Kirschner et  al. also observed rapid growth of non O1 
and non-O139 strain in the presence of dissolved organic 
carbon and water temperature [41]. It is therefore a major 
challenge to determine the role of these seemingly innoc-
uous inhabitants in the development of new pathogenic 
strains capable of causing outbreaks.
Favourable environmental conditions
Vibrio cholerae thrive in 15% salinity, 30  °C water tem-
perature, and pH 8.5 [42]. In the absence of these optimal 
conditions it is difficult to isolate toxigenic strains from 
previously endemic regions. By contrast, epidemic peri-
ods occur during warmer water temperatures in com-
bination with elevated pH and plankton blooms, and it 
becomes easy to isolate toxigenic strains [42]. Montilla 
et al. found conversion from non 01 to 01 and vice versa 
in all microcosms of both artificial sea water and natu-
ral water at various temperatures [42]. They concluded 
that seroconversion from non-O1 to O1 occurred earli-
est (within 5 days) at a salinity of ~10% and temperatures 
near 35 °C [42]. A study in Bangladesh revealed that the 
highest number of clinical cases occur when the air tem-
perature is more than 28.66 °C and sunshine is more than 
4.13 h/day [43]. Increased environmental water tempera-
tures decrease multiplication time and hastened growth 
along with an increased detection rate of V. cholera [29]. 
This suggested a triggering factor which may be respon-
sible for enhancing the number of organisms under cer-
tain environmental conditions [29]. V. cholerae O1 El Tor 
and O139 are able to form a three-dimensional biofilm 
on surfaces, providing a microenvironment [12]. Within 
Page 4 of 6Chowdhury et al. Ann Clin Microbiol Antimicrob  (2017) 16:10 
the biofilm, the organisms can survive during inter-epi-
demic periods. Biofilm formation is dependent on the 
expression of an exopolysaccharide (EPS). Expression of 
the vps synthesis genes, encoded in two gene clusters on 
the larger chromosome (vpsA-K and vpsL-Q), is required 
for the synthesis of EPS [12]. These gene clusters show 
higher expression at the time of increased salinity and 
water temperature [12]. Lu et al. in China also found that, 
spatiotemporal serotype shifts (Ogawa, Inaba and O139) 
generally correlated with the variations in the pulsed-
field gel electrophoresis patterns (PIV, PIIIc, PIa, PIIIb, 
PIIIa, PIb, and PII) [11]. These patterns largely influenced 
by seasonal variations particularly rainfall due to forma-
tion of bio film [11].
Plankton load and role of chitin
Sunlight, temperature, and nutrients all influence the 
growth of phytoplankton (green, red and blue-green) and 
aquatic plants, which in turn raise the pH of the surround-
ing water to favour growth of V. cholera [44]. Blue-green 
algae are a reservoir of V. cholera [44]. Heavy loads of phy-
toplankton produce food for zooplankton in the next level 
of the food chain. Various chitinous organisms (whose 
exoskeleton is formed by the polysaccharide chitin), e.g. 
copepods, amphipods, and other crustaceans (crabs, 
lobsters and shrimp) are prevalent among zooplankton 
populations [45]. Chitin is thin and provides flexibility 
to these organisms [45]. If chitin is not degraded, high 
levels of carbon and nitrogen remain insoluble and inac-
cessible to most organisms [29]. Using chitinase, marine 
bacteria including Vibrio spp. play a significant role in chi-
tin remineralisation, so very little chitin can be detected 
in aquatic sediments [29]. In addition to providing a food 
source for Vibrios and enhancing survival under starva-
tion conditions, chitin also offers protection to V. cholerae 
at low temperatures and under acidic conditions such 
as the human gut. This could be important if copepods 
carrying V. cholerae are ingested in drinking water [29]. 
Such protection is likely to play an important role in the 
expanding and changing epidemiology of cholera.
Recent studies suggest that chitin facilitates and regulates 
competence-mediated horizontal gene transfer in V. chol-
era by expressing Chi A2 and TfoX [13, 46]. The serocon-
version between O1 El Tor and O139 Bengal during the 
1992 epidemic in Bangladesh and India could be due  to 
this factor [46]. The activity of Chi A2 and the expression 
of TfoX gene could be influenced by environmental condi-
tions such as high salinity and water temperature [13].
Other environmental factors
Other influences under investigation include sea surface 
height, river discharge, climate variables that affect water 
levels and salinity [47]. Cholera is primarily a waterborne 
disease. Sanitation facilities, provision of safe drinking 
water and good infrastructure for sewage treatment in 
industrialized nations has made cholera extremely rare. 
Outbreak studies done in Odisha, India found a clear rela-
tionship between sewage contaminated water and chol-
era epidemics [48]. Several field surveys in West Bengal 
and Gujrat revealed cholera outbreaks related to sewage 
leaks from municipality pipelines and local overpopula-
tion [49–51]. In Africa, water source contamination due 
to weak sanitary infrastructure is considered the main 
risk factor for cholera [52]. It is inevitable that poor sani-
tary conditions, overcrowding with the majority of people 
living below the poverty line, lack of proper sewage dis-
posal systems and improper water supply, all provide ideal 
transmission conditions for cholera once it is introduced 
into a community. In future as an effect of global warming 
these conditions could worsen in many parts of the world.
Prevention by vaccine
An extensive review of vaccines is beyond the scope of 
this review, but the benefits of vaccinations merit high-
lighting. Although the ideal vaccine is yet to be developed, 
some promising vaccines have been licensed. Among 
them oral killed cholera vaccines (OCVs) are particularly 
helpful in the control and prevention of outbreaks. A sys-
tematic meta-analysis found the overall vaccine efficacy 
was 52% during the first year and 62% during the second 
year with less protectiveness in children under 5  years 
of age [53]. Other limitations to this approach are the 
necessity of multiple doses, limited evidence of long term 
protection, production costs etc. [54]. Single dose admin-
istration of oral vaccine is also protective and can reduce 
the logistic requirements for mass vaccination campaigns 
[55]. A single dose of the inactivated/killed oral vaccine, 
‘Shanchol’ was found to be efficacious in older children 
(≥5 years of age) and in adults in Bangladesh which is a 
high cholera endemic setting [55]. Though the currently 
available and licensed cholera vaccines do not confer life-
long 100% protection they are increasingly recognised as 
valuable tools in the containment of cholera outbreaks. 
New funding mechanisms and the creation of the interna-
tional cholera vaccine stockpile are helping to make OCVs 
globally available [56].
Recent research has focused on alternative delivery 
systems such as micro particles, proteoliposomes, LPS 
subunit, DNA vaccine and rice seeds containing toxin 
subunits [57]. Although a fully ideal vaccine has yet to be 
designed, these new approaches show promise.
Future directions
Analysis of global temperature data led the Inter-Gov-
ernmental Panel for Climate Change to the conclusion 
that the average global temperature over land and ocean 
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surfaces has risen by 0.85  °C (0.65–1.06) in the period 
from 1880 to 2012 [58]. They predicted that global sur-
face temperature will rise by 1.5  °C relative to 1850 by 
the end of the twenty-first century (2081–2100) [58]. Cli-
matologists also estimate that the sea level has risen by 
about 1  mm/year in recent decades, caused by thermal 
expansion [29]. These events will change the diversity of 
cholera epidemiology throughout the world in the future. 
Spontaneous seroconversion and rapid transduction 
between environmental and toxigenic strains giving rise 
to the emergence of new epidemic strains could become 
a global issue. How this happens, and what the impact of 
climate change will be is a matter of ongoing debate. The 
potential risk of the presence of virulence factors in dif-
ferent environmental (non-toxigenic) strains as well as 
the possible role of global warming is an important area 
for future research.
Conclusion
Cholera cannot be imminently eradicated as it is a native 
species of the aquatic eco system. It is found in close asso-
ciation with various algae and crustaceans which are also 
natural inhabitants of water. But the disease is preventable 
with implementation of public health measures to ensure 
adequate sanitation and safe water supply. Climate change 
is challenging the health sector. Meta-analysis and math-
ematical model have demonstrated that the burden of 
vector borne diseases like malaria, leishmaniasis, menin-
gococcal meningitis, viral encephalitis, dengue, chikungu-
nya, giardiasis, toxoplasmosis etc. will increase in coming 
years in the tropics and beyond [59, 60]. The licensing of 
several oral cholera vaccines has added a promising tool 
to the traditional cholera control strategies namely safe 
water, sanitation and hygiene improvements.
With changing climate patterns more countries may 
become at risk of cholera, and there is a high risk of 
further pandemics. Interdisciplinary analysis and inte-
grated prevention strategies are mandatory. Mathemati-
cal modelling of the disease in relation to climate offers 
a first step to identify the key environmental and cli-
mate parameters associated with disease variability. The 
development of an effective early warning system based 
on climate data could help to prevent and control future 
outbreaks. It may become possible to integrate real-time 
monitoring of oceanic regions, climate variability and 
epidemiological and demographic population dynamics 
to predict cholera outbreaks and support the design of 
cost-effective public health strategies.
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